Bijal Shah, MD, MS Hematology/Oncology H. Lee Moffic Cancer Center
In the video, Bijal Shah, MD, MS discusses the significance of CAR T-cell therapy in treating B-cell Acute Lymphoblastic Leukemia (B-ALL) at the H. Lee Moffic Cancer Center. Shaw emphasizes the need to integrate CAR T-cell therapy early with novel agents, particularly in low disease burden scenarios, to improve outcomes for adults with B-ALL.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
Traditional chemotherapy’s limitations in terms of efficacy and toxicity are highlighted. The session sparked engaging discussions, with time constraints despite numerous questions. Shaw commends the impressive quality of speakers and their impactful presentations. The video offers valuable insights into B-ALL treatment and CAR T-cell therapy’s potential to revolutionize patient care.